跳至主要内容
临床试验/NCT05117515
NCT05117515已完成不适用

Retrospective Monocentric, Observational PMCF - Study on the Performance and Safety of Uni-Graft® K DV Patch in Patients With Vascular Reconstructions

Aesculap AG1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
200
试验地点
1
主要终点
Restenosis Rate in postoperative Course

研究概览

简要总结

Uni-Graft® K DV Patch is marketed in Europe since 1999 for reconstructive interventions of the deep femoral, femoral and iliac artery and was also indicated for carotid interventions until 01/2020. Previous studies focused on the clinical performance of different patch materials used for patch angioplasty in different indications, without specifying the product or manufacturer. Thus, it is not surprising that there is a limited amount of published literature available describing the use of the Uni-Graft® K DV Patch in the clinical routine. Therefore, the aim of the present non-interventional study (NIS) is to close this gap by collecting and evaluating existing safety and performance data documented in the clinical routine especially during the application of the Uni-Graft® K DV Patch.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • written informed consent
  • treated with Uni-Graft® K DV Patch for reconstructive interventions of the carotid, deep femoral, femoral and iliac artery

排除标准

  • Use of the Uni-Graft® K DV Patch if allergies to components of the patch are known
  • Use of the Uni-Graft® K DV Patch in case of a known hypersensitive reaction to the patch and / or its components (e.g. polyethylene terephthalate).
  • No use of Uni-Graft® K DV Patch
  • Use of Uni-Graft® K DV Patch outside the intended use of the product at the date of application

结局指标

主要结局

Restenosis Rate in postoperative Course

时间窗: approximately up to 3 months after Implantation

Retrospective evaluation of restenosis rate from information documented in the patient file: the NASCET is an angiographic measurement recommended by the "North American Symptomatic Carotid Endarterectomy Trial"-Group. According to the NASCET-Method the grade of stenosis in relation to the diameter of the ACI distal to the stenosis in the area of the parallel arterial wall is measured.

次要结局

  • Rate of postoperative nerve lesions(approximately up to 3 months after Implantation)
  • Rate of patch related infections(approximately up to 3 months after Implantation)
  • Rate of postoperative pseudoaneurysm(approximately up to 3 months after Implantation)
  • Rate of Intraoperative stroke(intraoperatively)
  • Rate of postoperative stroke(approximately up to 3 months after Implantation)
  • Primary and secondary patency rate(approximately up to 3 months after Implantation)
  • Postoperative bleeding(approximately up to 3 months after Implantation)
  • Freedom of re-intervention rate(approximately up to 3 months after Implantation)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验